David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.
[read the full story...]The role of the gut microbiome in treatment-resistant schizophrenia
Nuala Murray explores a recent Australian case-control study that looks at the associations between changes in gut microbiota and schizophrenia diagnosis, treatment resistance, and clozapine response.
[read the full story...]Is short sleep linked to risk of psychosis and could inflammation be a factor?
Amy Ferguson summarises a recent study published by researchers in Birmingham, which suggests that persistent shorter sleep in childhood may increase the risk of psychotic experiences.
[read the full story...]KarXT: an innovative and promising treatment for schizophrenia
Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.
[read the full story...]Cognition and heterogeneity in first-episode psychosis before antipsychotic treatment
Ana Veic looks at an updated systematic review which suggests that patients with psychosis display cognitive difficulties very early in the disease process, and concludes this variation in cognitive function should prompt individual clinical assessments to optimise care.
[read the full story...]Here comes the sun: associations between daily light exposure and psychiatric disorders
Emiliana Tonini summarises a large-scale cross-sectional study, which suggests that encouraging individuals to increase their exposure to bright natural light during the day and minimise exposure to artificial light at night may help with our mental health.
[read the full story...]Just how good are antipsychotics at preventing relapse? Bridging the efficacy-effectiveness gap
Samei Huda summarises a new network meta-analysis in the Lancet Psychiatry on the efficacy and effectiveness of antipsychotics for schizophrenia in research settings, such as randomised controlled trials, versus real-world and clinical settings.
[read the full story...]Lived experience perspectives of acceptance and commitment therapy for people with psychosis
Charlotte Huggett reflects on a qualitative study exploring the perspectives of people with psychosis receiving Acceptance and Commitment Therapy following a first episode of psychosis.
[read the full story...]Sensing someone who isn’t really there: what is felt-presence?
Tyler Elliot summarises a recent literature review that summarises the philosophical, phenomenological, clinical, and non-clinical correlates of felt presence.
[read the full story...]Compassion-focused therapy for psychosis: study suggests it’s feasible and acceptable, so what next?
Ellen Iredale and Poppy Brown summarise a case-series study on compassion‐focused therapy for distressing hallucinations and delusions in psychosis, suggesting the potential to benefit people with psychosis.
[read the full story...]